gzr102
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 8, 2025 (NCT06974487)
Timeline
Indications
Studied for
Mechanism of action
- Insulin receptorAGONIST
INSR agonist
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07055386 | Phase 2 | Aug 7, 2025 | Gan and Lee Pharmaceuticals, USA |
| NCT06974487 | Phase 1 | May 8, 2025 | Gan and Lee Pharmaceuticals, USA |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gan and Lee Pharmaceuticals, USA | For profit | 2 | 2 | 2 | 2025 |
1 organizations
Page 1 / 1